GROWTH HORMONE INSENSITIVITY - 11/09/11
Doi : 10.1016/S0031-3955(05)70484-3
Arlan L. Rosenbloom, MD a, Ron G. Rosenfeld, MD b, Jaime Guevara-Aguirre, MD c
a Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida (ALR)
b Department of Pediatrics, Doernbecher Memorial Hospital for Children, Oregon Health Sciences University, Portland, Oregon (RGR)
c Institute of Endocrinology, Metabolism and Reproduction, Quito, Ecuador (JGA)
Plan
| Address reprint requests to Arlan L. Rosenbloom, MD, Department of Pediatrics, University of Florida College of Medicine, Box 100296, Gainesville, FL 32610–0296 Supported in part by grants from the March of Dimes Birth Defects Foundation, NIH grant DK-45830, the National Organization for Rare Disorders, Inc, and Pharmacia Peptide Hormones. |
© 1997
W. B. Saunders Company. Publié par Elsevier Masson SAS. Tous droits réservés.© 1994
© 1994
© 1994
Vol 44 - N° 2
P. 423-442 - avril 1997 Retour au numéro
Article précédent
- NEW DEVELOPMENTS IN CONGENITAL LIPOID ADRENAL HYPERPLASIA AND STEROIDOGENIC ACUTE REGULATORY PROTEIN
- Paul Saenger
- NEW PERSPECTIVES ON THE BIOLOGY AND TREATMENT OF X-LINKED HYPOPHOSPHATEMIC RICKETS
- Thomas O. Carpenter
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?